Aplicativos de saúde móvel no tratamento de doenças cardiovasculares

Abstract

The continued growth in health spending has led to diverse needs for care. Thus, it is necessary to develop mechanisms for articulation between the sectors involved in the production, incorporation and use of technologies in the health system. Given the current scenario of increased mortality from cardiovascular disease (CVD) in which it is found in Brazil, it is expected that the use of applications for smartphones helping patients with CVD is promising, but the lack of a comprehensive guiding structure is the main barrier to standardize data collection and integration, which creates insecurity for professionals and users. Therefore, this work aims to review the benefit and adherence strategies in the use of the health application in the process of pharmacotherapeutic management and medication adherence for patients with CVD. Regarding the methodological procedures, the research was a narrative review of the literature and consists of articles researched in the academic library: PubMed, where 7 studies were selected, and the duration of the studies occurred from February 2019 to May 2020. The result found was that the use of mobile health applications as an addictive tool is effective in pharmacotherapeutic management and medication adherence for patients with CVD. However, more rigor by regulatory bodies and the establishment of evidence-based guidelines are necessary to increase the credibility of the apps. It is concluded that new strategies, which help to improve the clinical outcome, are essential for the management of CVD, since this disease is still the most prevalent, according to the Ministry of Health, in the follow-up of mortality and morbidity among chronic non-communicable diseases in Brazil.